Colin Gaynor

Colin Gaynor is a Senior Director in Global Project Management for Late Stage Oncology at AstraZeneca, a position held since June 2014, where responsibilities include advancing oncology molecules from preclinical to late-stage development, with a focus on Alliance Programmes. Prior experience includes serving as a Project Manager in R&D at MedImmune from September 2009 to June 2014, overseeing a Biologics portfolio and collaborating with stakeholders on project planning and risk management. Earlier roles at Pfizer Ltd spanned from September 2001 to September 2009, including leadership as Pharmaceutical Sciences Project Leader and as Supply Chain Project Manager/Team Leader, involving clinical programme support and drug supply strategy development. Colin Gaynor holds a PhD in Pharmacology and Biochemistry from Aston University, earned between 1994 and 1999.